Chengcheng Dai Selected Research

Levodopa (L Dopa)

12/2022	Levodopa responsiveness and white matter alterations in Parkinson's disease: A DTI-based study and brain network analysis: A cross-sectional study.
6/2022	A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chengcheng Dai Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 01/2023 - 06/2022
1	Epilepsy (Aura) 11/2023
1	Seizures (Absence Seizure) 11/2023
1	Neuroinflammatory Diseases 01/2023
1	Tremor (Tremors) 06/2022
1	Disease Progression 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Iron Deficiencies 01/2021

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2023
2	Levodopa (L Dopa)FDA LinkGeneric 12/2022 - 06/2022
1	Adenosine Triphosphate (ATP)IBA 11/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2023
1	SynucleinsIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2023
1	IronIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	osimertinibIBA 01/2021

Therapy/Procedure

1	Therapeutics 06/2022